PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

NCT07332247 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Nasopharangeal Cancer
Recurrent Nasopharynx Carcinoma

Interventions

RADIATION: Selective re-irradiation
RADIATION: Immediate re-irradiation

Sponsor

Sun Yat-sen University